Larry I Magpantay Selected Research

Larry I Magpantay Research Topics

Disease

9	Acquired Immunodeficiency Syndrome (AIDS) 10/2023 - 01/2013
8	Inflammation (Inflammations) 10/2023 - 02/2014
7	Neoplasms (Cancer) 11/2023 - 01/2013
6	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 01/2016
5	Lymphoma (Lymphomas) 01/2023 - 01/2013
2	Hodgkin Disease (Hodgkin's Disease) 11/2023 - 01/2017
1	Kaposi Sarcoma (Kaposi's Sarcoma) 10/2023
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2023
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2023
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2023
1	Ovarian Neoplasms (Ovarian Cancer) 01/2021
1	Ovarian Epithelial Carcinoma 01/2021
1	Multiple Myeloma 01/2021
1	Carcinogenesis 01/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Chronic Disease (Chronic Diseases) 01/2017
1	Necrosis 07/2015
1	B-Cell Lymphoma (Lymphoma, B Cell) 02/2014
1	Ascites 01/2013

Drug/Important Bio-Agent (IBA)

13	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2013
5	CytokinesIBA 01/2021 - 02/2014
4	ChemokinesIBA 10/2023 - 01/2017
4	Type II Tumor Necrosis Factor ReceptorsIBA 10/2023 - 07/2015
4	Interleukin-10 (Interleukin 10)IBA 01/2023 - 02/2014
4	Interleukin-6 (Interleukin 6)IBA 01/2017 - 02/2014
3	LigandsIBA 10/2023 - 01/2013
3	InterleukinsIBA 10/2023 - 02/2014
2	Interferon-gamma (Interferon, gamma)IBA 10/2023 - 07/2015
2	Rituximab (Mabthera)FDA Link 01/2022 - 01/2016
2	B-Cell Activating FactorIBA 01/2021 - 07/2015
1	Chemokine CCL17IBA 11/2023
1	Proteins (Proteins, Gene)FDA Link 10/2023
1	EndoglinIBA 10/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2023
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 10/2023
1	C-Reactive ProteinIBA 10/2023
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2023
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 10/2023
1	Etoposide (VP 16)FDA LinkGeneric 10/2023
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2023
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 10/2023
1	ORALIT (ORS)IBA 01/2023
1	CD40 Ligand (CD40L)IBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Interleukin-8 (Interleukin 8)IBA 01/2021
1	Chemotactic FactorsIBA 01/2021
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2017
1	Immunoglobulin E (IgE)IBA 01/2017
1	succinyl- interleukin-2IBA 07/2015
1	Lipopolysaccharide ReceptorsIBA 07/2015
1	Immunoglobulins (Immunoglobulin)IBA 02/2014
1	NeopterinIBA 02/2014
1	Tumor Biomarkers (Tumor Markers)IBA 01/2013
1	Chemokine ReceptorsIBA 01/2013
1	Neutralizing AntibodiesIBA 01/2013

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 10/2023 - 01/2016
3	Therapeutics 10/2023 - 01/2016
1	Art Therapy 10/2023
1	Aftercare (After-Treatment) 01/2022
1	Highly Active Antiretroviral Therapy (HAART) 01/2021